Eli Lilly LLY
NYSE LLY
$1,284.64 +44.30 (+3.57%)
As of: Oct 20, 2026 · 3:59 PM EDT

Eli Lilly (LLY) Non-Current Assets (2009 - 2026)

Updated

Eli Lilly's Non-Current Assets was $77.61 billion in Q2 2026, up 52.0% from $51.07 billion a year earlier and up 25.7% from the prior quarter.

Analysis

Eli Lilly (LLY) Non-Current Assets (2009 - 2026) Analysis & Trends

At the end of FY2025, Non-Current Assets at Eli Lilly came in at $56.85 billion, up 23.6% from FY2024.

  • Non-Current Assets has now increased for seven consecutive years, with a five-year compound annual growth rate of 14.3% (FY2020 to FY2025).
  • In earlier years, Non-Current Assets was $45.98 billion in FY2024 (+20.1%), $38.28 billion in FY2023 (+21.7%), $31.46 billion in FY2022 (+3.6%) and $30.35 billion in FY2021 (+4.1%).
  • The Q2 2026 figure marks the highest quarterly Non-Current Assets in data going back to Q2 2009.
  • Compared with a year earlier, Non-Current Assets has increased for 15 straight quarters, with growth averaging 27.1% over the last eight quarters.
  • The best year-over-year quarter for Non-Current Assets over five years was Q2 2026 (growth of 52.0%); the worst was Q2 2022 (a decline of 1.9%).
  • Per Business Quant data, LLY's Non-Current Assets in the three quarters before Q2 2026 was $61.74 billion (Q1 2026), $56.85 billion (Q4 2025) and $52.86 billion (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 77.61 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn 141.29 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn 101.45 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn 125.00 Mn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 94.68 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn 87.87 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn 60.68 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn 35.42 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn 159.77 Bn
10 Vertex Pharmaceuticals 130.00 Bn 102.01 Bn 2.84 Bn 14.88 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 77.61 Bn
Mar 31, 2026 61.74 Bn
Dec 31, 2025 56.85 Bn
Sep 30, 2025 52.86 Bn
Jun 30, 2025 51.07 Bn
Mar 31, 2025 48.13 Bn
Dec 31, 2024 45.98 Bn
Sep 30, 2024 44.19 Bn
Jun 30, 2024 41.67 Bn
Mar 31, 2024 38.75 Bn
Dec 31, 2023 38.28 Bn
Sep 30, 2023 34.91 Bn
Jun 30, 2023 33.48 Bn
Mar 31, 2023 32.35 Bn
Dec 31, 2022 31.46 Bn
Sep 30, 2022 29.82 Bn
Jun 30, 2022 29.95 Bn
Mar 31, 2022 29.95 Bn
Dec 31, 2021 30.35 Bn
Sep 30, 2021 30.38 Bn
API Access

Eli Lilly Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-assets&ticker=LLY&period=max&api_key=YOUR_API_KEY